XT
SBFM

XTX Topco’s Sunshine Biopharma SBFM Stock Holding History

XTX Topco’s Portfolio SBFM Stock Details SBFM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$22.3K Buy
2,146
+530
+33% +$6.25K ﹤0.01% 3522
2025
Q4 		$19.9K Buy
+1,616
New +$25.5K ﹤0.01% 3060
2024
Q3 		– Sell
-220
Closed -$18.4K – 2539
2024
Q2 		$18.4K Buy
220
+217
+7,233% +$103K ﹤0.01% 1624
2024
Q1 		$3.25K Buy
3
+2
+200% +$5.88K ﹤0.01% 1745
2023
Q4 		$4.75K Buy
+1
New +$5.69K ﹤0.01% 1478

Other funds holding SBFM

Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
National Bank of Canada
National Bank of Canada Montreal, Quebec, Canada $112B AUM 31.26% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
CA
CoreCap Advisors Southfield, Michigan $3.39B AUM 31.21% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

XTX Topco's SBFM Position: Q1 2026 in Review

XTX Topco increased its Sunshine Biopharma (SBFM) stake by 33% in Q1 2026, buying an estimated $6.25K and bringing the position to 2,146 shares worth $22.3K. The position accounts for ﹤0.01% of the portfolio, ranked #3522.

XTX Topco first reported a position in SBFM in Q4 2023 and has held it in 5 quarters since. 8 funds tracked by Wall St. Rank hold SBFM as of Q1 2026.

  • XTX Topco held 2,146 shares of Sunshine Biopharma worth $22.3K as of Q1 2026.
  • XTX Topco bought 530 Sunshine Biopharma shares in Q1 2026, an estimated $6.25K.
  • Sunshine Biopharma made up ﹤0.01% of XTX Topco's portfolio in Q1 2026, its #3522 holding.
  • XTX Topco first reported a position in Sunshine Biopharma in Q4 2023 and has held it in 5 quarters since.
  • 8 funds tracked by Wall St. Rank held Sunshine Biopharma as of Q1 2026.

Based on XTX Topco's 13F filing for Q1 2026, filed 15 May 2026.